BIOMOJO LLC — Department of Defense SBIR Phase II: DHA191-002
BIOMOJO LLC — SBIR Phase II award from Department of Defense.
- Amount
- $2,196,027
- Agency
- Department of Defense · Defense Health Program
- Program / Phase
- SBIR · Phase II
- Topic
- DHA191-002
- Solicitation
- 19.1
- NAICS
- —
- Place of performance
- NC
- Period
- 2022-06-02 → 2025-01-25
Description
The purpose of this SBIR topics is to define, demonstrate, develop, and test an Intelligent Patient Simulation software architecture to be used for building intelligent patient simulators that provide realistic medical training experiences, by leveraging natural language processing and advanced Artificial Intelligence (AI) technologies.